TORONTO, March 16, 2023 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market Research's database, titled "Whole Genome and Exome Sequencing Market" with 100+ market data Tables, Pie Charts, Graphs & Figures spread through pages and easy-to-understand detailed analysis. Whole Genome and Exome Sequencing market report brings together a meticulous study of the present and upcoming opportunities to elucidate the future investment in the Whole Genome and Exome Sequencing industry. This report introduces top to bottom evaluation of the Whole Genome and Exome Sequencing industry including empowering technologies, key trends, market drivers, challenges, standardization, regulatory landscape, opportunities, future guide, value chain, ecosystem player profiles, and strategies. This report is a valuable source of assistance for companies and individuals that offers industry chain structure, business strategies, and proposals for new project investments. The credible Whole Genome and Exome Sequencing report also analyses various inhibitors as well as motivators of the market in both quantitative and qualitative manners to make available accurate information to the end users.
An excellent Whole Genome and Exome Sequencing market report describes a complete market analysis with inputs from industry experts. While formulating this global market document, the following aspects are kept in view and include market type, organization size, availability on-premises, end-users organization type, and availability in areas such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The world-class market research analysis brings together a vast marketplace clearly into the focus. The research studies of the Whole Genome and Exome Sequencing market report help evaluate several important parameters that can be mentioned as an investment in a rising market, the success of a new product, and expansion of market share.
Data Bridge Market Research analyses that the whole genome and exome sequencing market was valued at USD 1080.16 million in 2021 and is further estimated to reach USD 7310 million by 2029, and is expected to grow at a CAGR of 27% during the forecast period of 2022 to 2029.
Download the Exclusive Sample of the Whole Genome and Exome Sequencing Market Report in PDF Version @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-whole-genome-and-exome-sequencing-market
The whole genome sequencing helps to provide rich information regarding single nucleotide, structural, or copy number variants, while exome sequencing often makes more sense when time or resources are limited. Exome sequencing is also known as whole exome sequencing (WES), and is a genomic procedure for sequencing all of the protein-coding regions of genes in a genome.
Genomic research has had a huge impact on health care over the years. The genomics revolution has accelerated the transformation of medicine and biomedical sciences. Costs for Whole Genome Sequencing are falling, prompting a gold rush for market participants. New consumers, new technologies, and new specialties are all on the rise. A wide range of well-funded players is competing for market share on a genuinely global arena, in a setting reminiscent of the emergence of the internet business.
Whole genome sequencing helps to provide rich information regarding single nucleotide, structural, or copy number variants, while exome sequencing often makes more sense when time or resources are limited. Exome sequencing is also known as whole exome sequencing (WES), and is a genomic procedure for sequencing all of the protein-coding regions of genes in a genome.
Opportunities
In addition, the growing adoption of personalized medicine is further estimated to provide potential opportunities for the growth of the whole genome and exome sequencing market in the coming years.
Recent Development
- In January 2020, The "Genome India Project" was started by the Department of Biotechnology (DBT) (GIP). The goal of the initiative is to collect 10,000 genetic samples from Indian residents in order to create a reference genome. Precision health, rare genetic illnesses, the mutation spectrum of genetic and complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research are some of the areas of attention for this project.
Some of the major players operating in the Whole Genome and Exome Sequencing market are:
- 10x Genomics, Inc. (US)
- 23andME Inc. (US)
- Abbott (US)
- AccuraGen Inc. (US)
- Adaptive Biotechnologies (US)
- Admera Health, LLC (US)
- Agena Bioscience, Inc. (US)
- Agilent Technologies, Inc. (US)
- Akonni Biosystems, Inc. (US)
- Ancestry (US)
- Anchor Dx (China)
- ARUP Laboratories (US)
- Asuragen (US)
- Baylor Genetics (US)
- Beckman Coulter, Inc. (US)
- BD (US)
- BGI Genomics (China)
- Bioarray S.L. (US)
- Biocept, Inc. (US)
Get the Complete PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-whole-genome-and-exome-sequencing-market
The investment made in the study would provide you access to information such as:
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
- Country-wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Market Size by application/industry verticals
- Market Projections/Forecast
Whole Genome and Exome Sequencing Market Dynamics
Major factors that are expected to boost the growth of the whole genome and exome sequencing market in the forecast period are as follows:
- Rise in the prevalence of cancer
The most major element driving this market's growth is the rise in cancer incidence and expanding uses of next-generation sequencing in cancer research.
- Low cost and high speed of the Wes technology
When compared to whole genome sequencing, whole exome sequencing has a lower cost which will further be anticipated to propel the growth of the market.
- Rise in the acceptance of next-generation sequencing methods
The total market is being driven by growth in the acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer.
Restraints/Challenges
On the other hand, the dearth of skilled professionals and high reliability on grants is further projected to impede the growth of the whole genome and exome sequencing market in the targeted period. However, the ethical and legal concerns regarding to whole exome sequencing might further challenge the growth of the whole genome and exome sequencing market in the near future.
To Know More About This Research Report, Visit @ https://www.databridgemarketresearch.com/reports/global-whole-genome-and-exome-sequencing-market
Whole Genome and Exome Sequencing Market: Segmentation
Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
Products and Services
- Products
- Systems
- Kits
- Services
- Sequencing Services
- Data Analysis Services
Applications
- Diagnostics
- Cancer
- Monogenic Disorders
- Diabetes
- Drug Discovery and Development
- Personalized Medicine
- Agriculture and Animal Research
End-user
- Research Center
- Academic and Government Institutions
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Highlights of the Whole Genome and Exome Sequencing Market Report:
- Comprehensive overview of the Whole Genome and Exome Sequencing market along with an analysis of the changing dynamics of the market
- Impact of the technological developments and R&D advancements on the Whole Genome and Exome Sequencing market
- Regional and global analysis of the market players, including their market share and global position
- Growth Assessment of various market segments throughout the forecast period
- Information about profit-making strategies and developmental strategies of major companies and manufacturers
- Insightful information for the new entrants willing to enter the market
- Details and insights about business expansion strategies, product launches, and other collaborations
- The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Market Overview
- Global Whole Genome and Exome Sequencing Market, By Technology
- Global Whole Genome and Exome Sequencing Market, By Products and Services
- Global Whole Genome and Exome Sequencing Market, By Application
- Global Whole Genome and Exome Sequencing Market, By End User
- Global Whole Genome and Exome Sequencing Market, By Region
- Global Whole Genome and Exome Sequencing Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Grab the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-whole-genome-and-exome-sequencing-market
Browse Related Reports:
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered to more than 40% of fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge is adept in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfaction rate.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
